Participants 57 98 3
patients with active rheumatoid arthritis
Participants 353 509 5
Patients ages ≥18 years with active RA with an inadequate response to ≥1 tumor necrosis factor inhibitor (TNFi) and receiving stable background methotre
Participants 1854 1920 3
 in patients with active RA and a previous inadequate response to 
